Not Counted: Clinical Trials Of New HIV Treatments Are Failing Women

A recent article reported that The low representation of women in clinical trials has led to some efficacy and safety differences between men and women being missed, reports Dr Shuang Zhou of the United States Food and Drug Administration (FDA). African-American women were particularly underrepresented in clinical trials of new antiretrovirals.

Women make up the majority of people with HIV globally, but there is a chronic underrepresentation of cisgender women in antiretroviral clinical trials. This lack of representation results in sex-based differences being unknown. Some side effects, such as weight gain and rashes, have been reported more frequently by female patients.

You can read the full article here.